Conference Programme 23 September 2021

08.30 Welcome (Pär Hallberg)
08.40 Presentation of centres and activities, 13 min per country
09.45 BREAK
Presentations from European drug information centres:
10.00 Germany (Dorothea Strobach)
10:30 Russia (Ksenia Zagorodnikova)
11:00 Spain (Carla Sans Pola)
11:30 LUNCH
12:30 Czech Republic (Petra Rozsívalová)
13:00 Croatia (Suzana Mimica Matanovic)
13:30 BREAK & VIRTUAL SOCIAL ACTIVITY
14:30 Workshop: How do we approach a question, which resources do we use,
and how do we present the answer?
15:45 Summing up
16:30 End of day 1

Conference Programme 24 September 2021

08:30 QT-prolongation, clinical aspects (Stefan Lönnerholm)
09:30 BREAK
09:45
10:30
Minimize risk with QT-prolonging drugs (Jessica Schubert)
QT-prolonging drugs, discussion (Stefan Lönnerholm, Jessica Schubert)
10:45 BREAK
11:00 How do we assess renal function for drug dosing decisions? 
(Anna-Karin Hamberg)
12:00 LUNCH & VIRTUAL SOCIAL ACTIVITY
13:00 Dosing of drugs in patients with liver impairment
(Mari Thörn, Elin Lindhagen)
14:00 Intravenous compatibility of drugs
(Kaveh Teimori)
15:00 COFFEE & SUMMING UP
15:30
Swedish drug information centre discussion (Swedish LICs only)
16:30 End of conference

Invited Speakers

Anna-Karin Hamberg, pharmacist, Clinical Chemistry and Pharmacology, Uppsala University Hospital
Stefan Lönnerholm, MD, Section of Cardiology, Uppsala University Hospital
Jessica Schubert, MD, Clinical Chemistry and Pharmacology, Uppsala University Hospital
Mari Thörn, MD, Medical Products Agency, Uppsala
Elin Lindhagen, pharmacist, Medical Products Agency, Uppsala
Kaveh Teimori, pharmacist, Hospital Pharmacy Västra Götaland Region